Indeed, some studies have reported that in situ overexpression of gal-9 was associated with more efficient immune functions, a more favorable clinical outcome, or a decrease in tumor migration and invasion, e.g., in breast cancer or gastric tumors [115,116,117]. This evidence concerns the gene LGALS9 and neoplasm.